These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7704565)

  • 21. [The role of proteolytic enzyme inhibitors in the development and occurrence of chronic obstructive lung diseases].
    Ubaĭdullaev AM; Kazakov KS; Liverko IV; Chernik MB
    Ter Arkh; 1994; 66(3):42-5. PubMed ID: 8202851
    [No Abstract]   [Full Text] [Related]  

  • 22. [Proteases, their inhibitors and lung diseases].
    Liu CE; Wang JL
    Zhonghua Jie He He Hu Xi Za Zhi; 1989 Aug; 12(4):237-40. PubMed ID: 2700081
    [No Abstract]   [Full Text] [Related]  

  • 23. Neutrophil enzymes in the lung: regulation of neutrophil elastase.
    Lonky SA; McCarren J
    Am Rev Respir Dis; 1983 Feb; 127(2):S9-15. PubMed ID: 6402963
    [No Abstract]   [Full Text] [Related]  

  • 24. Elastolytic proteases: inflammation resolution and dysregulation in chronic infective lung disease.
    Taggart CC; Greene CM; Carroll TP; O'Neill SJ; McElvaney NG
    Am J Respir Crit Care Med; 2005 May; 171(10):1070-6. PubMed ID: 15695494
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of leukocyte granule proteinases by natural inhibitors isolated from colostrum and bull seminal plasma.
    Stancíková M; Cechová D; Trnavaský K
    Hoppe Seylers Z Physiol Chem; 1980 Jul; 361(7):1129-33. PubMed ID: 6997172
    [No Abstract]   [Full Text] [Related]  

  • 26. Protease injury in the development of COPD: Thomas A. Neff Lecture.
    Chapman HA; Shi GP
    Chest; 2000 May; 117(5 Suppl 1):295S-9S. PubMed ID: 10843961
    [No Abstract]   [Full Text] [Related]  

  • 27. Potential problems in designing elastase inhibitors for therapy.
    Travis J; Fritz H
    Am Rev Respir Dis; 1991 Jun; 143(6):1412-5. PubMed ID: 2048830
    [No Abstract]   [Full Text] [Related]  

  • 28. [Protease inhibitors].
    Rodríguez Cuartero A
    Rev Esp Enferm Apar Dig; 1973 Feb; 39(3):331-6. PubMed ID: 4699121
    [No Abstract]   [Full Text] [Related]  

  • 29. Electrophoretic mobility of leukocyte elastase of normal subjects and patients with chronic obstructive pulmonary disease.
    Taylor JC; Kueppers F
    Am Rev Respir Dis; 1977 Sep; 116(3):531-6. PubMed ID: 409318
    [No Abstract]   [Full Text] [Related]  

  • 30. Potential novel therapies for chronic obstructive pulmonary disease.
    Barnes PJ
    Novartis Found Symp; 2001; 234():255-67; discussion 267-72. PubMed ID: 11199100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Aggressive induction of pulmonary emphysema in animals: an approach to emphysema in man?].
    Reichart E
    Agressologie; 1984 Sep; 25(8):903-5. PubMed ID: 6391235
    [No Abstract]   [Full Text] [Related]  

  • 32. [Serum elastin peptide concentration and human leukocyte elastase/antiproteinase balance in peripheral obstructive atherosclerosis].
    Mohácsi A; Kozlovszky B; Seres I; Kiss I; Misz M; Fülöp T
    Orv Hetil; 1996 Jan; 137(1):15-21. PubMed ID: 8721858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of smoking on the status of immunity and on antiprotease protection].
    Golub NI
    Ter Arkh; 1996; 68(1):64-7. PubMed ID: 8644038
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bronchial mucus modifiers, antioxidants and antiproteases].
    Polu JM; Chabot F; Wallaert B
    Rev Mal Respir; 1993; 10(2):87-100. PubMed ID: 8502804
    [No Abstract]   [Full Text] [Related]  

  • 35. [Experimental therapy of periodontosis with elastase inhibitor].
    Barabash RD; Levitskiĭ AP
    Patol Fiziol Eksp Ter; 1976; (6):58-63. PubMed ID: 1018962
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of elastase inhibitors on the course of hemorrhagic pancreatitis].
    Levitskiĭ AP; Stefanov AV; Veretennikov AL
    Patol Fiziol Eksp Ter; 1974; (6):57-60. PubMed ID: 4444844
    [No Abstract]   [Full Text] [Related]  

  • 37. Proteolysis-induced pathomechanisms in acute inflammation and related therapeutic approaches.
    Jochum M; Machleidt W; Fritz H
    Agents Actions Suppl; 1993; 42():51-69. PubMed ID: 8356931
    [No Abstract]   [Full Text] [Related]  

  • 38. [Prerequisites for the use of proteinase inhibitors in lung diseases].
    Pilipchuk VN; Butvin SN
    Probl Tuberk; 1987; (9):64-9. PubMed ID: 3321041
    [No Abstract]   [Full Text] [Related]  

  • 39. COPD: new developments and therapeutic opportunities.
    Rogers DF; Barnes PJ
    Trends Pharmacol Sci; 1999 Sep; 20(9):352-4. PubMed ID: 10515795
    [No Abstract]   [Full Text] [Related]  

  • 40. 7-alkylidenecephalosporin esters as inhibitors of human leukocyte elastase.
    Buynak JD; Rao AS; Ford GP; Carver C; Adam G; Geng B; Bachmann B; Shobassy S; Lackey S
    J Med Chem; 1997 Oct; 40(21):3423-33. PubMed ID: 9341917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.